Silverberg, JI; Wollenberg, A; Legat, FJ; Laquer, VT; Armstrong, AW; Herranz, P; Naldi, L; Ahmad, F; Ulianov, L; Piketty, C.
Maintenance of efficacy and safety with nemolizumab at week 48: results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis
BRIT J DERMATOL. 2024; 191:
Doi: 10.1093/bjd/ljae266.041
[Poster]
Web of Science
FullText
FullText_MUG